Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia
Clinical trial NCT04403763 · TERMINATED
Trial details
- NCT number
- NCT04403763
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2022-12-05
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.